Direct Presentation Is Sufficient for an Efficient Anti-Viral CD8 T Cell Response

English version České info

The extent to which direct- and cross-presentation (DP and CP) contribute to the priming of CD8⁺ T cell (T_CD8+) responses to viruses is unclear mainly because of the difficulty in separating the two processes. Hence, while CP in the absence of DP has been clearly demonstrated, induction of an anti-viral T_CD8+ response that excludes CP has never been purposely shown. Using vaccinia virus (VACV), which has been used as the vaccine to rid the world of smallpox and is proposed as a vector for many other vaccines, we show that DP is the main mechanism for the priming of an anti-viral T_CD8+ response. These findings provide important insights to our understanding of how one of the most effective anti-viral vaccines induces immunity and should contribute to the development of novel vaccines.

Vyšlo v časopise: Direct Presentation Is Sufficient for an Efficient Anti-Viral CD8 T Cell Response. PLoS Pathog 6(2): e32767. doi:10.1371/journal.ppat.1000768
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000768

Souhrn

Zdroje

1. LauLL

JamiesonBD

SomasundaramT

AhmedR

1994 Cytotoxic T-cell memory without antigen. Nature 369 648 652

2. WelshRM

SelinLK

Szomolanyi-TsudaE

2004 Immunological memory to viral infections. Annu Rev Immunol 22 711 743

3. FangM

SigalLJ

2005 Antibodies and CD8+ T Cells Are Complementary and Essential for Natural Resistance to a Highly Lethal Cytopathic Virus. J Immunol 175 6829 6836

4. XuR-H

FangM

Klein-SzantoA

SigalLJ

2007 Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection. Proc Natl Acad Sci U S A 104 10992 10997

5. LenzLL

ButzEA

BevanMJ

2000 Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med 192 1135 1142

6. SigalLJ

CrottyS

AndinoR

RockKL

1999 Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398 77 80

7. SigalLJ

RockKL

2000 Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and - independent pathways of antigen presentation. J Exp Med 192 1143 1150

8. HeathWR

BelzGT

BehrensGM

SmithCM

ForehanSP

2004 Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199 9 26

9. RockKL

1996 A new foreign policy: MHC class I molecules monitor the outside world. Immunology Today 17 131 137

10. MeliefCJ

2003 Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? Eur J Immunol 33 2645 2654

11. WilsonNS

BehrensGM

LundieRJ

SmithCM

WaithmanJ

2006 Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 7 165 172

12. ZinkernagelRM

2002 On cross-priming of MHC class I-specific CTL: rule or exception? Eur J Immunol 32 2385 2392

13. AmigorenaS

2003 Y in X priming. Nat Immunol 4 1047 1048

14. LizeeG

BashaG

TiongJ

JulienJP

TianM

2003 Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol 4 1065 1073

15. HeathWR

CarboneFR

2001 Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1 126 134

16. SernaA

RamirezMC

SoukhanovaA

SigalLJ

2003 Cutting Edge: Efficient MHC Class I Cross-Presentation during Early Vaccinia Infection Requires the Transfer of Proteasomal Intermediates between Antigen Donor and Presenting Cells. J Immunol 171 5668 5672

17. NorburyCC

BastaS

DonohueKB

TscharkeDC

PrinciottaMF

2004 CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304 1318 1321

18. RestifoNP

BacikI

IrvineKR

YewdellJW

McCabeBJ

1995 Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol 154 4414 4422

19. WherryEJ

PuorroKA

PorgadorA

EisenlohrLC

1999 The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J Immunol 163 3735 3745

20. PorgadorA

YewdellJW

DengY

BenninkJR

GermainRN

1997 Localization, quantitation, and in situ detection of specific peptide- MHC class I complexes using a monoclonal antibody. Immunity 6 715 726

21. PrinciottaMF

FinziD

QianSB

GibbsJ

SchuchmannS

2003 Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18 343 354

22. GilbertPA

McFaddenG

2006 Poxvirus cancer therapy. Recent Pat Antiinfect Drug Discov 1 309 321

23. GherardiMM

EstebanM

2005 Recombinant poxviruses as mucosal vaccine vectors. J Gen Virol 86 2925 2936

24. NorburyCC

MalideD

GibbsJS

BenninkJR

YewdellJW

2002 Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3 265 271

25. HickmanHD

TakedaK

SkonCN

MurrayFR

HensleySE

2008 Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol 9 155 165

26. MaX

SernaA

XuRH

SigalLJ

2009 The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation. J Immunol 182 4601 4607

27. KarttunenJ

SandersonS

ShastriN

1992 Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 89 6020 6024

28. SandersonS

ShastriN

1994 LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 6 369 376

29. HogquistKA

JamesonSC

HeathWR

HowardJL

BevanMJ

1994 T cell receptor antagonist peptides induce positive selection. Cell 76 17 27

30. ClarkeSR

BarndenM

KurtsC

CarboneFR

MillerJF

2000 Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol 78 110 117

31. KurtsC

KosakaH

CarboneFR

MillerJF

HeathWR

1997 Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 186 239 245

32. Nikolic-ZugicJ

BevanMJ

1990 Role of self-peptides in positively selecting the T-cell repertoire. Nature 344 65 67

33. BadovinacVP

HaringJS

HartyJT

2007 Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 26 827 841

34. TscharkeDC

KarupiahG

ZhouJ

PalmoreT

IrvineKR

2005 Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201 95 104

35. QuC

NguyenVA

MeradM

RandolphGJ

2009 MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells. J Immunol 182 3650 3659

36. DolanBP

GibbsKDJr

Ostrand-RosenbergS

2006 Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J Immunol 177 6018 6024

37. SollidLM

VaageJT

2006 Cross-dressing T cells go wild. Nat Med 12 611 612

38. SmythLA

HerreraOB

GolshayanD

LombardiG

LechlerRI

2006 A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation 82 S15 18

39. SmythLA

HarkerN

TurnbullW

El-DoueikH

KlavinskisL

2008 The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J Immunol 181 3212 3220

40. ShenL

SigalLJ

BoesM

RockKL

2004 Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21 155 165

41. LarssonM

FonteneauJF

SomersanS

SandersC

BickhamK

2001 Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur J Immunol 31 3432 3442

42. RamirezMC

SigalLJ

2002 Macrophages and Dendritic Cells Use the Cytosolic Pathway to Rapidly Cross-Present Antigen from Live, Vaccinia-Infected Cells. J Immunol 169 6733 6742

43. GasteigerG

KastenmullerW

LjapociR

SutterG

DrexlerI

2007 Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol 81 11925 11936

44. BastaS

ChenW

BenninkJR

YewdellJW

2002 Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells. J Immunol 168 5403 5408

45. ShenX

WongSB

BuckCB

ZhangJ

SilicianoRF

2002 Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes. J Immunol 169 4222 4229

46. AckermanAL

GiodiniA

CresswellP

2006 A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25 607 617

47. JuntT

MosemanEA

IannaconeM

MassbergS

LangPA

2007 Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450 110 114

48. ShastriN

GonzalezF